SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review

被引:0
作者
Xiaohui Jing
Menglin Han
Xiaoxuan Wang
Li Zhou
机构
[1] Tianjin University of Traditional Chinese Medicine,School of Chinese Materia Medica
[2] Tianjin University of Traditional Chinese Medicine,College of Pharmaceutical Engineering of Traditional Chinese Medicine
来源
BMC Infectious Diseases | / 23卷
关键词
COVID-19; Vaccine; Breakthrough infection; Older adults; Meta-analysis; Systematic review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 264 条
[1]  
Wang J(2021)The impact of age difference on the efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis Front Immunol 12 758294-16
[2]  
Tong Y(2021)Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Lancet 398 1407-8
[3]  
Li D(2021)Clinical characterization and genomic analysis of samples from COVID-19 breakthrough infections during the second wave among the various states of India Viruses 13 1782-1939
[4]  
Li J(2010)Prediction of institutionalization in the elderly A systematic review Age Ageing 39 31-82
[5]  
Li Y(2021)Lower urinary tract symptoms and sexual dysfunction in male: a systematic review and meta-analysis Front Med (Lausanne) 8 653510-20
[6]  
Tartof SY(2021)Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine Nat Commun 12 63791-49
[7]  
Slezak JM(2021)Association of Prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar JAMA-J AM MED ASSOC 326 1930-27
[8]  
Fischer H(2021)The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data EBioMedicine 72 103574-14
[9]  
Hong V(2022)COVID-19 vaccination breakthrough infections in a real-world setting: using community reporters to evaluate vaccine effectiveness Infect Drug Resist 15 5167-37
[10]  
Ackerson BK(2022)Trends and correlates of breakthrough infections with SARS-CoV-2 Front Public Health 10 856532-29